by Travis Johnson, Stock Gumshoe | February 19, 2010 5:55 pm
This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.
Source URL: https://www.stockgumshoe.com/2010/02/february-idea-of-the-month-a-value-trap-that-can-grow/
Copyright ©2024 Stock Gumshoe unless otherwise noted.
Any concerns that the Gov. will end funding for Fanny and Fred? Seems that it would put NLY and HTS on the ropes.
Just wanted to say thanks. As a reader of your daily(regular) news letter for the last six months I felt it necessary to become an Irregular . Your positive tone is refreshing and is a good mix with a couple of the “Doomsday” columns I also read. Your regular column has shown me patients and if this column is any indication of the Irregulars I can see my understanding of fundamentals is definitely going to be positively impacted. Who knows I might even beat the “Thinkolator” one of these years.
Once again thanks, and keep up the sleuthing. This rookie appreciates it.
I really like the low-key objective tone that characterizes GumShoe. It’s worth joining.
Two uncharacteristic teasers are out recently. One is a biotech firm being touted under the news from”Mining Speculator: “Our in-house biotech expert Steve Christ has found a breakthrough biotech company that has had unmatched success in boosting the human immune system against cancer, killer viruses, infectious disease and more…” It’s strange for a mining newsletter to be touting any biotech firm. I’ve actually done OK with a couple of McCoach’s recommendations that are junior mining stocks.
The other IS a junior mining firm, symbol AMOK, being touted by emails, not in Mining Speculator, but instead in emails conveyed from the Weiss group–a group that tends not to recommend junior mining stocks. Any insights?
Great write up on an interesting company. Agree that on a straight forward P/E basis the company looks expensive but it appears to have a lot of things going for it aside from being a newsletter darling. The company is back down $6.55 which may be an attractive entry point if it manages to find support.